Kurosh Parsi (M Kang, Mina Kang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Phlebology

Experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

The Australasian journal of dermatology

University of New South Wales (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of New South Wales Mar 5o 2013 - Nov 15o 2019

Australia

PHD :: Faculty of Medicine

Publications

Lois Zhang, Kate Ng, James P Pham, Samuel Thoo, Anes Yang, Kurosh Parsi, David Ewan Connor, Steven Kossard, Kurosh Parsi
Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders. Phlebology (2023)
Kurosh Parsi, Lois Zhang, Mark Steven Whiteley, Selene Vuong, Kurosh Parsi, Nikita Naidu, Joseph Grace, David Ewan Connor
899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Phlebology (2023)
Mandy Wong, Kurosh Parsi, Kenneth Myers, Marianne De Maeseneer, Joseph A Caprini, Attilio Cavezzi, David Ewan Connor, Alun Huw Davies, Sergio Gianesini, Jean-Luc Gillet, Louis Grondin, Jean-Jérôme Guex, Claudine Hamel-Desnos, Nick Morrison, Giovanni Mosti, Alvaro Orrego, Hugo Partsch, Eberhard Rabe, Pauline Raymond-Martimbeau, Michel Schadeck, Roberto Simkin, Lorenzo Tessari, Paul K Thibault, Jorge H Ulloa, Mark Steven Whiteley, Takashi Yamaki, Steven Zimmet, Kurosh Parsi, Selene Vuong, Anes Yang, Lois Zhang
Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology (2023)
Kurosh Parsi, Anes Yang, Patricia Hannaford, David Ewan Connor, Kurosh Parsi
Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms. Phlebology 37 (6) (2022)
Kurosh Parsi, Anes Yang, Patricia Hannaford, David Ewan Connor, Kurosh Parsi
Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies. Phlebology 37 (9) (2022)
Kurosh Parsi, Kurosh Parsi
Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy. The Australasian journal of dermatology 63 (2) (2022)
Kurosh Parsi, David Ewan Connor, Kurosh Parsi
Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes. Phlebology 37 (5) (2022)
Kurosh Parsi, Jessica Szu-Chia Chen, Melissa Radjenovic, Anes Yang, Grant H Y Feng, Dedee Frances Murrell
An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study. Experimental dermatology 30 (11) (2021)
Kurosh Parsi, Asli Bilgic Temel, M Radjenovic, Dedee Frances Murrell
Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based review. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)
Kurosh Parsi, Stefania Roberts, Mina Kang, Stephen Benson, Luke Baker, Ivor Berman, Lourens J Bester, David E Connor, Paul Dinnen, Joseph Grace, Andrew Stirling, Nabeel Ibrahim, Christopher Lekich, Adrian Lim, Luke Matar, Sanjay Nadkarni, Peter Paraskevas, Christopher Rogan, Paul K Thibault, Simon Thibault, Andre van Rij, Anes Yang
Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology. Phlebology 35 (3) (2019)

Kurosh Parsi.css-eqlu8i{font-size:small;padding-left:4px;} (M Kang, Mina Kang)

Publication Activity (10 Years)

Top Topics

Top Venues

Kurosh Parsi (M Kang, Mina Kang)